Cardiff Oncology (XE7C) Q3 2026 Earnings Report
DE:XE7C Q3 2026 EPS Results
- Actual EPS
- ―
- Consensus EPS
- -EUR 0.12
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.15
DE:XE7C Q3 2026 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- EUR 72.42K
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/29/2026
- Time
- TBA
- Conference Call
- Thursday, October 29, 2026
DE:XE7C Upcoming Earnings
Cardiff Oncology's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:XE7C Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | -0.1 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.12- | -0.15 | ― | |
| Aug 11, 2026 | 2026 (Q2) | -0.11-0.13 | -0.19 | 33.33% (+0.06) | |
| May 14, 2026 | 2026 (Q1) | -0.12-0.16 | -0.18 | 10.00% (+0.02) | |
| Feb 24, 2026 | 2025 (Q4) | -0.17-0.10 | -0.2 | 50.00% (+0.10) | |
| Nov 06, 2025 | 2025 (Q3) | -0.18-0.15 | -0.22 | 32.00% (+0.07) | |
| Jul 29, 2025 | 2025 (Q2) | -0.17-0.19 | -0.23 | 19.23% (+0.04) | |
| May 08, 2025 | 2025 (Q1) | -0.17-0.18 | -0.2 | 9.09% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -0.22-0.20 | -0.19 | -4.76% (-0.01) | |
| Nov 07, 2024 | 2024 (Q3) | -0.24-0.22 | -0.2 | -13.64% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
